Zenas BioPharma Inc. (ZBIO)
NASDAQ: ZBIO
· Real-Time Price · USD
16.34
0.02 (0.12%)
At close: Aug 21, 2025, 10:12 AM
Zenas BioPharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Net Income | -52.22M | -33.57M | -52.6M | -38.61M | -37.98M | -27.8M | -24.59M | 35.61M | -29.05M | -19.1M | -18.99M |
Depreciation & Amortization | -923K | 23K | 33K | 36K | 35K | 33K | 30K | 26K | 29K | 28K | 25K |
Stock-Based Compensation | 6.04M | 5.39M | 5.5M | 2.84M | 1.54M | 947K | 1.14M | 1M | 669K | 687K | 289K |
Other Working Capital | 17.25M | -11.74M | 3.44M | 1.15M | 5.64M | 3.46M | 4.45M | -3.62M | -866K | -7.58M | 1.51M |
Other Non-Cash Items | 200K | -29K | -344K | 125K | 291K | 853K | 455K | 173K | 10.21M | 191K | 309K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 5.16M | -8.86M | 8.87M | 4.54M | 5.16M | 6.87M | 7.57M | -4.96M | -2.77M | -7.87M | 1.24M |
Operating Cash Flow | -41.74M | -37.05M | -38.55M | -31.06M | -30.96M | -19.1M | -15.4M | 31.85M | -20.91M | -26.06M | -17.13M |
Capital Expenditures | n/a | -18K | -74K | n/a | -35K | -22K | -17K | n/a | n/a | n/a | -1.07M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -126.55M | -99.11M | -9.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 14.26M | 12.86M | 6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -26.76M | n/a | n/a | n/a | n/a | n/a | n/a | -1M |
Investing Cash Flow | -112.29M | -86.27M | -3.73M | -26.76M | -35K | -22K | -17K | n/a | n/a | n/a | -1.07M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20M | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.72M | n/a | -4.4M | -439K | -766K | -656K | 50K | n/a | 11K | 55K | 59.39M |
Financial Cash Flow | 1.72M | 99K | 1.85M | 233.98M | 177.74M | -614K | 50K | 20M | 11K | 55K | 59.39M |
Net Cash Flow | -152.55M | -123.28M | -40.3M | 176.11M | 146.78M | -19.7M | -15.45M | 51.85M | -20.73M | -26.01M | 41.21M |
Free Cash Flow | -41.74M | -37.07M | -38.63M | -31.06M | -30.99M | -19.12M | -15.42M | 31.85M | -20.91M | -26.06M | -18.2M |